Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for MESALAMINE
- Alpha Lipoic Acid in Ulcerative Colitis
- Repurposing Fenofibrate in Modulating mTOR/NLRP3 Inflammasome in Patients With Ulcerative Colitis
- Fenofibrate in Ulcerative Colitis
- Prophylactic Mesalamine to Prevent Colitis Following Treatment With Ipilimumab/Nivolumab (Ipi/Nivo)
- the Efficacy and Safety of Diosmin in Patients With Ulcerative Colitis
- Metformin as Added on Therapy in Patients With Ulcerative Colitis
- Atorvastatin Efficacy and Safety in Patients With Ulcerative Colitis
- Pentoxifylline as Adjunctive Therapy in Patients With Ulcerative Colitis
- Metformin in Patients With Ulcerative Colitis Treated With Mesalamine
- A Study to Assess Adverse Events and Change in Disease Condition of Mesalamine Capsules in Children Aged 5 to 17 Years With Ulcerative Colitis
- HCQ for Non Europeans With Mild to Severe UC
- Mesalamine for Colorectal Cancer Prevention Program in Lynch Syndrome
- ABI-M201 in Adult Subjects With Mildly-to-Moderately Active Ulcerative Colitis
- Fecal Microbiota Therapy Vs 5-aminosalicylates for Induction of Remission in Newly Diagnosed Mild-moderately Active UC
- PRObiotic VSL#3® for Maintenance of Clinical and Endoscopic REMission in Ulcerative Colitis
- Randomized,Study of APRISO 375 mg Versus the Approved APRISO 375 mg Capsules in Healthy Male and Female Subjects
- Mesalamine for Colorectal Cancer Prevention Program in Lynch Syndrome
- Mercaptopurine Therapy in Ulcerative Colitis
- Mesalamine for Colorectal Cancer Prevention Program in Lynch Syndrome
- A Study to Investigate the Safety and Efficacy of LT-02 in Patients With Mesalamine Refractory Ulcerative Colitis (UC)
- To Evaluate the Efficacy and Safety of Rapamycin for Crohn's Disease-related Stricture
- Combination Corticosteroids+5-aminosalicylic Acids Compared to Corticosteroids Alone (for Ulcerative Colitis).
- Mesalamine 2 g Sachet for the Maintenance of Clinical and Endoscopic Remission in Ulcerative Colitis (UC)
- Mesalamine 4 g Sachet for the Induction of Remission in Active, Mild to Moderate Ulcerative Colitis (UC)
- A Phase 2a, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Trial of IBD98-M
- Fecal Microbiota Transplant (FMT) for Pouchitis
- Berberine Chloride in Preventing Colorectal Cancer in Patients With Ulcerative Colitis in Remission
- Standardized Fecal Microbiota Transplantation for Inflammatory Bowel Disease
- Phosphatidylcholine (LT-02) vs. Placebo vs. Mesalamine for Maintenance of Remission in Ulcerative Colitis (PROTECT-2)
- Pharmacokinetics of IBD98-M 400mg-57.5/Day in Healthy Volunteers
- Effects of Mesalamine and Amitriptyline on Irritable Bowel Syndrome
- Phosphatidylcholine (LT-02) for Induction of Remission in Ulcerative Colitis
- Taste Assessment Study of SHP429 in Healthy Adult Subjects
- Safety and Efficacy of MMX Mesalamine/Mesalazine in Pediatric Subjects With Mild to Moderate Ulcerative Colitis
- Therapeutic Equivalence Between Branded and Generic WARFArin Tablets in Brazil
- Correlation of Mesalamine Pharmacokinetics With Local Availability
- HMPL-004 Maintenance Treatment in Subjects With Mild to Moderate Ulcerative Colitis
- Mesalamine in Environmental Enteropathy
- A Phase III Trial of HMPL-004 in Patients With Mild to Moderate Active Ulcerative Colitis
- Standardized Fecal Microbiota Transplantation for Crohn&Apos;s Diseases
- Clinical Management of Childhood Intestinal Lymphoid Nodular Hyperplasia
- Cimzia Versus Mesalamine for Crohn's Recurrence
- Mesalamine for Uncomplicated Diverticular Disease: a Randomized, Double-blind, Placebo-controlled Study
- Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis
- Predicting Response to Standardized Pediatric Colitis Therapy
- Sulfamethoxazole Drug Interaction Study With MMX® Mesalazine/Mesalamine
- A Study to Evaluate Safety and Efficacy of Telotristat Etiprate (LX1606) in Participants With Acute, Mild to Moderate Ulcerative Colitis
- Amoxicillin Drug Interaction Study With MMX® Mesalazine/Mesalamine
- Metronidazole Drug Interaction Study With MMX® Mesalazine/Mesalamine
- The Effect of Long-Acting Mesalamine on Post-Infective Irritable Bowel Syndrome- A Pilot Study
- Ciprofloxacin XR Drug Interaction Study With MMX® Mesalazine/Mesalamine
- Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis
- Efficacy of Mesalamine in Diarrhea-predominant Irritable Bowel Syndrome (dIBS)
- Curcumin + Aminosalicylic Acid (5ASA) Versus 5ASA Alone in the Treatment of Mild to Moderate Ulcerative Colitis
- Budesonide Versus Mesalazine Versus Placebo in Lymphocytic Colitis
- Once Versus Twice Daily Mesalamine to Induce Remission in Pediatric Ulcerative Colitis
- Mesalamine Granules for Irritable Bowel Syndrome (IBS) With Diarrhea
- Clinical Trial With Mesalamine 1g Suppositories
- Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis
- Ability to Maintain or Achieve Clinical and Endoscopic Remission With MMX Mesalamine Once Daily in Adults With Ulcerative Colitis
- Evaluation of Efficacy of Mesalamine in the Long-term Prevention of Diverticulitis Flares
- Mesalamine to Reduce T Cell Activation in HIV Infection
- Targeting Oxidative Stress in Chronic Beryllium Disease
- A BE Study Comparing Mesalamine 400 mg to ASACOL® 400 mg in Patients With Mild To Moderately Active Ulcerative Colitis
- Study of the Safety and Tolerability of ALTH12 Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis
- Efficacy and Safety Study of MAX-002 Suppository Versus Placebo and Active Medicine in Mild to Moderate Ulcerative Proctitis
- Trial of Mesalamine for the Treatment of Active Microscopic Colitis
- Curcumin in Pediatric Inflammatory Bowel Disease
- A Study With Pentasa in Patients With Active Crohn's Disease
- Mesalamine 4 gm/60 mL Rectal Enema
- Bioavailability Study of Two Mesalamine 4 gm/60 ml Rectal Enema Formulations
- Mesalamine Pellet to Maintain Remission of Mild to Moderate Ulcerative Colitis
- Pharmacokinetics of Asacol 2.4 g/Day and Lialda 2.4 g/Day in Healthy Volunteers
- Mesalamine Pellet Formulation to Maintain Remission of Mild to Moderate Ulcerative Colitis
- Phase II Study of HMPL-004 in Patients With Ulcerative Colitis
- Dose Escalation and Remission (DEAR)
- PK Study of Encapsulated Mesalamine Granules in Healthy Volunteers
- Canadian Active & Maintenance Modified Pentasa Study
- Safety and Efficacy of AST-120 in the Treatment of Antibiotic-Refractory Pouchitis
- Safety and Efficacy of Asacol 4.8 g/Day Versus Asacol 2.4 g/Day (ASCEND I)
- Efficacy, Safety and Tolerability of AEB071 in Patients With Active, Moderate to Severe Ulcerative Colitis
- Asacol Acute Diverticulitis(DIVA)Study
- Medical Treatment of Colitis in Patients With Hermansky-Pudlak Syndrome
- Strategies in Maintenance for Patients Receiving Long-term Therapy (S.I.M.P.L.E.) With MMX (Multi-Matrix System) Mesalamine for Ulcerative Colitis (UC)
- Balsalazide Disodium vs. Mesalamine in Mildly to Moderately Active Ulcerative Colitis
- A Double Blind Study for the Treatment of Acute Ulcerative Colitis
- Safety and Compliance of Taking Mesalamine Once a Day in Pediatric Patients
- Long-Term Safety and Tolerability of Mesalamine Pellets in Participants With Ulcerative Colitis in Remission
- A Study of Asacol Absorption, Metabolism and Excretion in Children and Adolescents With Ulcerative Colitis.
- Asacol Dosing Study for Active Ulcerative Colitis
- Efficacy and Safety of SPD476 in Maintaining Remission in Patients With Ulcerative Colitis
- Trial of Growth Hormone Therapy in Pediatric Crohn's Disease
- Imuran (Azathioprine) Dose-Ranging Study in Crohn's Disease
- ISIS 2302-CS22, A 6-Week, Active-Controlled Clinical Study to Evaluate the Effectiveness of Alicaforsen (ISIS 2302) in Patients With Mild to Moderate Active Ulcerative Colitis
Clinical trials list
click for details